tumor RNA-pulsed autologous dendritic cells (Epitarget)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nametumor RNA-pulsed autologous dendritic cells (Epitarget)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapyVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsGlioma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNorway

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEpitarget AS

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEpitarget AS

Active IndicationsN/A

Inactive IndicationsGlioma

Other Information

ATC CodeN/A